BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab
Clinical trial NCT02054481 · COMPLETED
Trial details
- NCT number
- NCT02054481
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-11-01
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.